The mechanisms of cell death in focal cerebral ischemia highlight neuroprotective perspectives by anti-caspase therapy

Biochemical Pharmacology

Volumn 66, Issue 8, 2003, Pages 1643-1649

  Onténiente, Brigitte ^a   Couriaud, Cécile ^a   Braudeau, Jérôme ^a   Benchoua, Alexandra ^a   Guégan, Christelle ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Apoptosis; FLICE inhibitory protein; Flip; HIV1; Human immunodeficiency virus 1; IAP; Inhibitors of apoptosis; MCAO; Middle cerebral artery occlusion; Protein transduction domain; PTD; rCBF; Regional cerebral blood flow; TAT; TAT domain; Transactivator domain

Indexed keywords

CASPASE; CASPASE 3; CASPASE 7; CASPASE 9; CASPASE INHIBITOR; FLICE INHIBITORY PROTEIN; HYBRID PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; TRANSACTIVATOR PROTEIN; X LINKED INHIBITOR OF APOPTOSIS; ENZYME INHIBITOR;

AMINO ACID SEQUENCE; APOPTOSIS; BRAIN ISCHEMIA; CELL DEATH; CELL NUCLEUS; CELL ULTRASTRUCTURE; CONFERENCE PAPER; CYTOPLASM; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME STRUCTURE; GENE CONSTRUCT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN TARGETING; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STROKE; STRUCTURE ANALYSIS; VALIDATION PROCESS; ARTICLE; CEREBROVASCULAR ACCIDENT; DRUG ANTAGONISM; ENZYMOLOGY; PATHOLOGY;

APOPTOSIS; BRAIN ISCHEMIA; CASPASES; CEREBROVASCULAR ACCIDENT; ENZYME INHIBITORS; HUMANS;

EID: 0642375799     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00538-0     Document Type: Conference Paper

References (60)

1. Choi D.W. Ischemia induced neuronal apoptosis. Curr. Opin. Neurobiol. 6:1996;667-672.
2. Rinkerberger J.L., Korsmeyer S.J. Errors of homeostasis and deregulated apoptosis. Curr. Opin. Genet. Dev. 7:1997;589-596.
3. Martin L.J., Al-Abdulla N.A., Brambrink A.M., Kirsch J.R., Sieber F.E., Portera-Cailliau C. Neurodegeneration in excitotoxicity, global cerebral ischemia and target deprivation: a perspective on the contributions of necrosis and apoptosis. Brain Res. Bull. 46:1998;281-309.
4. Velier J.J., Ellison J.A., Kikly K.K., Spera P.A., Barone F.C., Feuerstein G.Z. Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat. J. Neurosci. 19:1999;5932-5941.
5. Guégan C., Sola B. Early and sequential recruitment of apoptotic effectors after focal permanent ischemia in mice. Brain Res. 856:2000;93-100.
6. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
7. Lukaszevicz A.C., Sampaïo N., Guégan C., Benchoua A., Couriaud C., Chevalier E., Sola B., Lacombe P., Onténiente B. High sensitivity of protoplasmic cortical astroglia to focal ischemia. J. Cereb. Blood Flow Metab. 22:2002;289-398.
8. Chen H., Chopp M., Schultz L., Bodzin G., Garcia J.H. Sequential neuronal and astrocytic changes after transient middle cerebral artery occlusion in the rat. J. Neurol. Sci. 118:1993;109-116.
9. Duggal N., Schmidt-Kastner R., Hakim A.M. Nestin expression in reactive astrocytes following cerebral ischemia in rats. Brain Res. 768:1997;1-9.
10. Onténiente B, Rasika S, Benchoua A, Guégan C. Molecular pathways in cerebral ischemia: cues to novel therapeutic strategies. Mol Neurobiol 2003;27: 33-72.
11. Benchoua A., Guégan C., Couriaud C., Hosseini H., Sampaio N., Morin D., Onténiente B. Specific caspase pathways are activated in the two stages of cerebral infarction. J. Neurosci. 21:2001;7127-7134.
12. Hartmann A., Troadec J.D., Hunot S., Kikly K., Faucheux B.A., Mouatt-Prigent A., Ruberg M., Agid Y., Hirsch E.C. Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J. Neurosci. 21:2001;2247-2255.
13. Benchoua A., Couriaud C., Guégan C., Tartier L., Couvert P., Friocourt G., Chelly J., Menissier-de Murcia J., Onténiente B. Active caspase-8 translocates into the nucleus of apoptotic cells to inactivate poly(ADP-ribose) polymerase-2. J. Biol. Chem. 277:2002;34217-34222.
14. Nicotera P., Leist M., Fava E., Berliocchi L., Volbracht C. Energy requirement for caspase activation and neuronal cell death. Brain Pathol. 10:2000;276-282.
15. Cecconi F. Apaf1 and the apoptotic machinery. Cell Death Differ. 6:1999;1087-1098.
16. Bratton S.B., Cohen G.M. Apoptotic death sensor: an organelle's alter ego? Trends Pharmacol. Sci. 22:2001;306-315.
17. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:2000;513-519.
18. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 403:2000;98-103.
19. Weber C.H., Vincenz C. The death domain superfamily: a tale of two interfaces? Trends Biochem. Sci. 26:2001;475-481.
20. Plenisla N, Moskowitz MA. Caspases in cerebral ischemia. In: Krieglstein J, Klumpp S, editors. Pharmacology of cerebral ischemia. Stuttgart: Medpharm Scientific; 2000. p. 137-43.
21. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T.-T., Vu V.L., Miller D.K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
22. Tewari M., Quan L.T., O'Rourke K., Desnoyers S., Zeng Z., Beider D.R., Poirier G. Yama/CPP 32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADR-ribose) polymerase. J. Biol. Chem. 274:1999;28379-28384.
23. Lippke J.A., Gu Y., Sarnecki C., Caron P.R., Su M.S. Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J. Biol. Chem. 271:1996;1825-1928.
24. Germain M., Affar E.B., D'Amours D., Dixit V.M., Salvesen G.S., Poirier G.G. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J. Biol. Chem. 274:1999;28379-28384.
25. Orth K., Chinnaiyan A.M., Garg M., Froelich C.J., Dixit V.M. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem. 271:1996;16443-16446.
26. Le D., Wu Y., Huang Z., Matsushita K., Plesnila N., Augustinack J.C., Hyman B.T., Yuan J., Kuida K., Flavell R.A., Moskowitz M.A. Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc. Natl. Acad. Sci. U.S.A. 99:2002;15188-15193.
27. Baliga B.C., Colussi P.A., Read S.H., Dias M.M., Jans D.A., Kumar S. Role of prodomain in importin-mediated nuclear localization and activation of caspase-2. J. Biol. Chem. 278:2003;4899-4905.
28. Loetscher H., Niederhauser O., Kemp J., Gill R. Is caspase-3 inhibition a valid therapeutic strategy in cerebral ischemia? Drug Discov. Today. 6:2001;671-680.
29. Gillardon F., Kiprianova I., Sandkuhler J., Hossmann K.A., Spranger M. Inhibition of caspases prevents cell death of hippocampal CA1 neurons, but not impairment of hippocampal long-term potentiation following global ischemia. Neuroscience. 93:1999;1219-1222.
30. von Coelln R., Kugler S., Bahr M., Weller M., Dichgans J., Schulz J.B. Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. J. Neurochem. 77:2001;263-273.
31. Endres M., Namura S., Shimizu-Sasamala M., Waeber C., Zhang L., Gomez-Isla T., Hyman B.T., Moskowitz M.A. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. 18:1998;238-247.
32. Himi T., Ishizaki Y., Murota S. A caspase inhibitor blocks ischemia-induced delayed neuronal death in the gerbil. Eur. J. Neurosci. 10:1998;777-781.
33. Lemaire C., Andreau K., Souvannavong V., Adam A. Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Lett. 425:1998;266-270.
34. Robertson G.S., Crocker S.J., Nicholson D.W., Schulz J.B. Neuroprotection by the inhibition of apoptosis. Brain Pathol. 10:2000;283-292.
35. Graczyk P.P. Caspase inhibitors - a chemist's perspective. Rest. Neurol. Neurosci. 14:1999;1-23.
36. Zhou Q., Snipas S., Orth K., Muzio M., Dixit V.M. Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J. Biol. Chem. 272:1997;7797-7800.
37. Deveraux Q.L., Reed J.C. IAP family proteins - suppressors of apoptosis. Genes Dev. 13:1999;239-252.
38. Tschopp J., Irmler M., Thome M. Inhibition of Fas death signals by FLIP. Curr. Opin. Immunol. 10:1998;552-558.
39. Deveraux Q.L., Leo E., Stennicke H.R., Welsh K., Salvesen G.S., Reed J.C. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 18:1999;5242-5251.
40. Guégan C., Vila M., Rosoklija G., Hays A.P., Przedborski S. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J. Neurosci. 21:2001;6569-6576.
41. Xu D., Bureau Y., McIntyre D.C., Nicholson D.W., Liston P., Zhu Y., Fong W.G., Crocker S.J., Korneluk R.G., Robertson G.S. Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J. Neurosci. 19:1999;5026-5033.
42. Yeh W.C., Itie A., Elia A.J., Ng M., Shu H.B., Wakeham A., Mirtsos C., Suzuki N., Bonnard M., Goeddel D.V., Mak T.W. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity. 12:2000;633-642.
43. Goltsev Y.V., Kovalenko A.V., Arnold E., Varfolomeev E.E., Brodianskii V.M., Wallach D. CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272:1997;19641-19644.
44. Inohara N., Koseki T., Hu Y., Nunez G. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10717-10722.
45. Micheau O., Thome M., Schneider P., Holler N., Tschopp J., Nicholson D.W., Briand C., Grutter M.G. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277:2002;45162-45171.
46. Rasper D.M., Vaillancourt J.P., Hadano S., Houtzager V.M., Seiden I., Keen S.L., Tawa P., Xanthoudakis S., Nasir J., Martindale D., Koop B.F., Peterson E.P., Thornberry N.A., Huang J., MacPherson D.P., Black S.C., Hornung F., Lenardo M.J., Hayden M.R., Roy S., Nicholson D.W. Cell death attenuation by 'Usurpin' a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ. 5:1998;271-288.
47. Defer G.L., Geny C., Ricolfi F., Fenelon G., Monfort J.C., Remy P., Villafane G., Jeny R., Samson Y., Keravel Y., Gaston A., Degos J.D., Peschanski M., Cesaro P., Nguyen J.P. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain. 119:1996;41-50.
48. Bachoud-Levi A.C., Remy P., Nguyen J.P., Brugieres P., Lefaucheur J.P., Bourdet C., Baudic S., Gaura V., Maison P., Haddad B., Boisse M.F., Grandmougin T., Jeny R., Bartolomeo P., Dalla Barba G., Degos J.D., Lisovoski F., Ergis A.M., Pailhous E., Cesaro P., Hantraye P., Peschanski M. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet. 356:2000;1975-1979.
49. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U.S.A. 91:1994;664-668.
50. Green M., Loewenstein P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell. 55:1988;1179-1188.
51. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 55:1988;1189-1193.
52. Schwarze S., Ho A., Vocero-Akbani A., Dowdy S. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 285:1999;1569-1572.
53. Kilic U., Kilic E., Dietz G.P., Bahr M. TAT-GDNF is protective after focal cerebral ischemia in mice. Stroke. 34:2003;1304-1310.
54. Dietz G.P., Kilic E., Bahr M. Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol. Cell. Neurosci. 21:2002;29-37.
55. Cao G., Pei W., Ge H., Liang Q., Luo Y., Sharp F.R., Lu A., Ran R., Graham S.H., Chen J. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 22:2002;5423-5431.
56. Kilic E., Dietz G.P., Hermann D.M., Bahr M. Intravenous TAT-Bcl-XL is protective after middle cerebral artery occlusion in mice. Ann. Neurol. 52:2002;617-622.
57. Asoh S., Ohsawa I., Mori T., Katsura K., Hiraide T., Katayama Y., Kimura M., Ozaki D., Yamagata K., Ohta S. Protection against ischemeic brain injury by protein therapeutics. Proc. Natl. Acad. Sci. U.S.A. 99:2002;17107-17112.
58. Vaux D.L., Korsmayer S.J. Cell death in development. Cell. 96:1999;245-254.
59. Ueki A., Isozaki T., Tomokuni A., Hatayama T., Ueki H., Kusaka M., Shiwa M., Arikuni H., Takeshita T., Morimoto K. Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemis lupus erythematous, as well as in healthy individuals. Clin. Exp. Immunol. 129:2002;556-561.
60. Shiraki K., Takase K., Nakano T. The emerging role of caspase inhibitors in gastrointestinal cancers. J. Gastroenterol. 37:2002;323-331.